Tonix Pharmaceuticals Holding Corp. financial data

Symbol
TNXP on Nasdaq
Industry
Pharmaceutical Preparations
Location
26 Main Street, Suite 101, Chatham, NJ
State of incorporation
NV
Fiscal year end
December 31
Former names
TAMANDARE EXPLORATIONS INC. (to 10/17/2011)
Latest financial report
10-K - Q4 2024 - Mar 18, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 296 % -5.86%
Quick Ratio 50.2 %
Debt-to-equity 27.3 % +45%
Return On Equity -143 % -63%
Return On Assets -112 % -52.1%
Operating Margin -1.35K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.43M shares -92.4%
Common Stock, Shares, Outstanding 4.39M shares
Entity Public Float 6.86M USD -59.7%
Common Stock, Value, Issued 4K USD +33.3%
Weighted Average Number of Shares Outstanding, Basic 736K shares -90.7%
Weighted Average Number of Shares Outstanding, Diluted 736K shares -90.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 10.1M USD
Cost of Revenue 7.77M USD
Research and Development Expense 40M USD -53.9%
General and Administrative Expense 29.9M USD +8.95%
Costs and Expenses 147M USD +16.4%
Operating Income (Loss) -137M USD -15.5%
Net Income (Loss) Attributable to Parent -130M USD -11.5%
Earnings Per Share, Basic -177 USD/shares
Earnings Per Share, Diluted -177 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 98.8M USD +296%
Accounts Receivable, after Allowance for Credit Loss, Current 3.68M USD
Inventory, Net 8.41M USD -38.4%
Other Assets, Current 2.13M USD
Assets, Current 119M USD +149%
Property, Plant and Equipment, Net 42.3M USD
Operating Lease, Right-of-Use Asset 565K USD -31.4%
Intangible Assets, Net (Excluding Goodwill) 120K USD -98.8%
Goodwill 965K USD
Other Assets, Noncurrent 951K USD -15.8%
Assets 163M USD +5.46%
Accounts Payable, Current 4.55M USD +20.2%
Contract with Customer, Liability, Current 1.82M USD -39.1%
Liabilities, Current 18.3M USD -3.06%
Operating Lease, Liability, Noncurrent 358K USD -43.4%
Liabilities 23.3M USD -52.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -255K USD -9.91%
Retained Earnings (Accumulated Deficit) -731M USD -21.6%
Stockholders' Equity Attributable to Parent 140M USD +32.3%
Liabilities and Equity 163M USD +5.46%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.6M USD +46.6%
Net Cash Provided by (Used in) Financing Activities -212K USD +98.2%
Net Cash Provided by (Used in) Investing Activities -108K USD +97.2%
Common Stock, Shares Authorized 1B shares +525%
Common Stock, Shares, Issued 4.39M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -17.9M USD +62.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 99.7M USD +286%
Deferred Tax Assets, Valuation Allowance 62.9M USD +38.2%
Deferred Tax Assets, Gross 62.9M USD +38.2%
Operating Lease, Liability 632K USD -29.9%
Payments to Acquire Property, Plant, and Equipment 108K USD -97.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -130M USD -11.4%
Lessee, Operating Lease, Liability, to be Paid 763K USD -39.2%
Property, Plant and Equipment, Gross 46.3M USD -53.4%
Operating Lease, Liability, Current 274K USD +1.48%
Lessee, Operating Lease, Liability, to be Paid, Year Two 142K USD -52.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 299K USD -1.97%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 56K USD -37.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 139K USD -2.11%
Deferred Tax Assets, Operating Loss Carryforwards 39.3M USD +19%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 101K USD -27.3%
Operating Lease, Payments 74K USD -46.4%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 476K USD
Depreciation, Depletion and Amortization 1.21M USD +35.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%